Author

F. Gruenschlaeger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:scRNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

S. Haas· 2 shared A. Kuck· 1 shared A. R. Itani· 1 shared A. Sedlmeier· 1 shared A. Trumpp· 1 shared B. Brors· 1 shared B. Durie· 1 shared B. J. Bouman· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. Haas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 27, 2023

Multiple myeloma long-term survivors display sustained immune alterations decades after first line therapy

R. Lutz, F. Gruenschlaeger, M. Simon…·S. Haas

This study examines immune changes in multiple myeloma survivors years after treatment, finding sustained immune alterations linked to residual disease and therapy.

DOI 10.1101/2023.05.27.542555

humanscRNA-seq

𝕏 PostBluesky

Cell BiologybioRxivPreprintMar 9, 2023

Single-cell time series analysis reveals the dynamics of in vivo HSPC responses to inflammation

B. J. Bouman, Y. Demerdash, S. Sood…·M. A. G. Essers

The paper uses single-cell time series analysis to study HSPC responses to IFN treatment, revealing heterogeneous gene responses and reduced myeloid differentiation.

DOI 10.1101/2023.03.09.531881

humanscRNA-seq

𝕏 PostBluesky